Two novel mutations in the EPM2A gene in a Korean patient with Lafora's progressive myoclonus epilepsy

[1]  M. T. Medina,et al.  Genotype-phenotype correlations for EPM2A mutations in Lafora's progressive myoclonus epilepsy: exon 1 mutations associate with an early-onset cognitive deficit subphenotype. , 2002, Human molecular genetics.

[2]  K. Yamakawa,et al.  Mutation screening for Japanese Lafora's disease patients: identification of novel sequence variants in the coding and upstream regulatory regions of EPM2A gene. , 2001, Molecular and cellular probes.

[3]  B. Minassian.  Lafora's disease: towards a clinical, pathologic, and molecular synthesis. , 2001, Pediatric neurology.

[4]  K. Yamakawa,et al.  Advances in the genetics of progressive myoclonus epilepsy. , 2001, American journal of medical genetics.

[5]  J. Serratosa,et al.  Mutational spectrum of the EPM2A gene in progressive myoclonus epilepsy of Lafora: high degree of allelic heterogeneity and prevalence of deletions , 2000, European Journal of Human Genetics.

[6]  K. Yamakawa,et al.  Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual-specificity phosphatase associated with polyribosomes. , 2000, Human molecular genetics.

[7]  S. Scherer,et al.  Mutation spectrum and predicted function of laforin in Lafora’s progressive myoclonus epilepsy , 2000, Neurology.

[8]  S. Scherer,et al.  Identification of new and common mutations in the EPM2A gene in Lafora disease , 2000, Neurology.

[9]  R. Michelucci,et al.  A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2). , 1999, Human molecular genetics.

[10]  S. Scherer,et al.  Genetic locus heterogeneity in Lafora's progressive myoclonus epilepsy , 1999, Annals of neurology.

[11]  S. Scherer,et al.  Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy , 1998, Nature Genetics.